Dec 16 (Reuters) - Integragen SA ALINT.PA :
* Announces collaboration agreement with investigators from
Piccolo to validate the role of biomarker Hsa-miR-31-3p in
metastic colorectal cancer
* Collaboration with Piccolo will try to confrim predictive
role of biomarker in response to anti-EGFR therapies in a
prospective phase III large-scale study
Source text for Eikon: ID:nBw7KjxBCa
Further company coverage: ALINT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Keywords: INTEGRAGEN/BRIEF